Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma

Anton Hagenbeek; Luis Fayad; Vincent Delwail; Jean Francois Rossi; Eric Jacobsen; Kazimierz Kuliczkowski; Brian K. Link; Lauren Pinter-Brown; John Radford; Andrzej Hellmann; Eve Gallop-Evans; Ira Gupta; Michael Arning; Kamilla Begtrup; Martin Schultz; Bo Bang; Charlotte A. Russell; Myron S. Czuczman

Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma

Anton Hagenbeek, Luis Fayad, Vincent Delwail, Jean Francois Rossi, Eric Jacobsen, Kazimierz Kuliczkowski, Brian K. Link, Lauren Pinter-Brown, John Radford, Andrzej Hellmann, Eve Gallop-Evans, Ira Gupta, Michael Arning, Kamilla Begtrup, Martin Schultz, Bo Bang, Charlotte A. Russell, Myron S. Czuczman

Division of Psychology & Mental Health

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	Undefined
Pages (from-to)	385-386
Number of pages	2
Journal	Blood
Volume	114
Issue number	22
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Hagenbeek, A., Fayad, L., Delwail, V., Rossi, J. F., Jacobsen, E., Kuliczkowski, K., Link, B. K., Pinter-Brown, L., Radford, J., Hellmann, A., Gallop-Evans, E., Gupta, I., Arning, M., Begtrup, K., Schultz, M., Bang, B., Russell, C. A., & Czuczman, M. S. (2009). Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma. Blood, 114(22), 385-386.

@article{ca381d15667948dba2891e195d43da29,

title = "Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma",

author = "Anton Hagenbeek and Luis Fayad and Vincent Delwail and Rossi, {Jean Francois} and Eric Jacobsen and Kazimierz Kuliczkowski and Link, {Brian K.} and Lauren Pinter-Brown and John Radford and Andrzej Hellmann and Eve Gallop-Evans and Ira Gupta and Michael Arning and Kamilla Begtrup and Martin Schultz and Bo Bang and Russell, {Charlotte A.} and Czuczman, {Myron S.}",

year = "2009",

language = "Undefined",

volume = "114",

pages = "385--386",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

number = "22",

}

Hagenbeek, A, Fayad, L, Delwail, V, Rossi, JF, Jacobsen, E, Kuliczkowski, K, Link, BK, Pinter-Brown, L, Radford, J, Hellmann, A, Gallop-Evans, E, Gupta, I, Arning, M, Begtrup, K, Schultz, M, Bang, B, Russell, CA & Czuczman, MS 2009, 'Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma', Blood, vol. 114, no. 22, pp. 385-386.

TY - JOUR

T1 - Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma

AU - Hagenbeek, Anton

AU - Fayad, Luis

AU - Delwail, Vincent

AU - Rossi, Jean Francois

AU - Jacobsen, Eric

AU - Kuliczkowski, Kazimierz

AU - Link, Brian K.

AU - Pinter-Brown, Lauren

AU - Radford, John

AU - Hellmann, Andrzej

AU - Gallop-Evans, Eve

AU - Gupta, Ira

AU - Arning, Michael

AU - Begtrup, Kamilla

AU - Schultz, Martin

AU - Bang, Bo

AU - Russell, Charlotte A.

AU - Czuczman, Myron S.

PY - 2009

Y1 - 2009

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000272725801115&KeyUID=WOS:000272725801115

M3 - Meeting Abstract

SN - 0006-4971

VL - 114

SP - 385

EP - 386

JO - Blood

JF - Blood

IS - 22

ER -

Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma

UN SDGs

Other files and links

Cite this